Immunic, Inc. — Income Charts
1 quarters of history · ending 2014-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$22K
Cost of Revenue
$13K
Gross Profit
$9K
R&D
$9M
D&A
$297K
Operating Income
$-12M
EBITDA
$-12M
Interest Expense
$14M
Interest Income
$2K
Net Income
$-11M
Gross Margin
40.9%
Operating Margin
-53981.8%
Net Margin
-48854.5%
ETR (Continuing Operations)
—
ETR Federal Statutory
—
ETR State + Local (pp)
—
ETR Foreign Differential (pp)
—
Income YoY Variation
-141.1%
Income QoQ Variation
—